Process for quantitative measurement of proteìna amyloid A; recombinant proteìna; antiserum specific for human serum acute phase.

摘要

Invention patent: b "process for quantitative measurement of proteu00ecna amyloid A; recombinant proteu00ecna; antiserum specific for human serum acute phase" d .Process for the quantitative determination of human serum amyloid a protein (the acute phase SAA), which comprises contacting a sample of a biological fluid with antibody specific for - SAA.The sample being interacted with an organic solvent before or simultaneously with the contact of the antibody.The organic solvent is properly an alcohol (C ~ 1 ~ C ~ 4 ~ and the antibody can be used in the solid phase and as a component of the detection system of a test imunossorvente linked to the enzyme.The process provides a sensitive and reliable measurement of the SAA and inflammatory state, which can be used for diagnosis and clinical management of both acute and chronic inflammatory conditions.